GLP-1 drugs increase rare ‘eye stroke’ linked to vision loss, hundreds of lawsuits allege
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that the medications caused NAION (nonarteritic anterior ischemic optic neuropathy), according to The Wall Street Journal. NAION is a rare eye condition in which … Read more